
Merck & Co has been forced to undertake a massive recall of its combination cholesterol-lowering drug Liptruzet in the US …

Merck is celebrating after its once-daily anti-cholesterol pill Liptruzet was approved by US regulators, expanding its indications. The drug – …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

